Organogenesis Holdings (ORGO) Current Taxes (2015 - 2018)
Organogenesis Holdings (ORGO) posted quarterly Current Taxes of $700000.0 for Q3 2018, up 47.37% quarter-over-quarter from $475000.0 in Q2 2018.
Organogenesis Holdings (ORGO) Current Taxes (2015 - 2018) Analysis & Trends
Organogenesis Holdings' Current Taxes history runs 4 years deep, the most recent figure standing at $700000.0 for Q3 2018.
- In Q3 2018, Current Taxes changed N/A year-over-year to $700000.0; the TTM figure through Sep 2018 stood at $700000.0 (changed N/A YoY), while the FY2017 annual figure was $100000.0, changed N/A from the prior year.
- Current Taxes for Q3 2018 stood at $700000.0, up from $475000.0 in the prior quarter.
- The five-year high for Current Taxes was $700000.0 in Q3 2018, with the low at $100000.0 in Q4 2017.
- The 4-year median for Current Taxes is $300000.0 (2016), against an average of $341666.7.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -355.54 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 138.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 739.89 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 46.00 Mn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 700,000.00 |
| Jun 30, 2018 | 475,000.00 |
| Mar 31, 2018 | 300,000.00 |
| Dec 31, 2017 | 100,000.00 |
| Sep 30, 2016 | 300,000.00 |
| Dec 31, 2015 | 175,000.00 |